ArriVent BioPharma, Inc. (AVBP)

ArriVent BioPharma Statistics

Total Valuation

AVBP has a market cap or net worth of $1.10 billion. The enterprise value is $792.68 million.

Market Cap	1.10B
Enterprise Value	792.68M

Important Dates

The last earnings date was Thursday, March 5, 2026, after market close.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

AVBP has 44.20 million shares outstanding. The number of shares has increased by 22.22% in one year.

Current Share Class	44.20M
Shares Outstanding	44.20M
Shares Change (YoY)	+22.22%
Shares Change (QoQ)	+2.46%
Owned by Insiders (%)	2.03%
Owned by Institutions (%)	66.21%
Float	27.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.24
P/TBV Ratio	3.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.83, with a Debt / Equity ratio of 0.00.

Current Ratio	12.83
Quick Ratio	12.06
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -58.88% and return on invested capital (ROIC) is -39.27%.

Return on Equity (ROE)	-58.88%
Return on Assets (ROA)	-36.49%
Return on Invested Capital (ROIC)	-39.27%
Return on Capital Employed (ROCE)	-57.79%
Weighted Average Cost of Capital (WACC)	9.73%
Revenue Per Employee	n/a
Profits Per Employee	-$3.20M
Employee Count	52
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.44% in the last 52 weeks. The beta is 1.00, so AVBP's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	+13.44%
50-Day Moving Average	22.32
200-Day Moving Average	21.07
Relative Strength Index (RSI)	57.77
Average Volume (20 Days)	528,281

Short Selling Information

The latest short interest is 7.05 million, so 15.94% of the outstanding shares have been sold short.

Short Interest	7.05M
Short Previous Month	7.22M
Short % of Shares Out	15.94%
Short % of Float	25.42%
Short Ratio (days to cover)	14.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-177.53M
Pretax Income	-166.31M
Net Income	-166.31M
EBITDA	n/a
EBIT	-177.53M
Earnings Per Share (EPS)	-$4.32

Balance Sheet

The company has $312.82 million in cash and $14,000 in debt, with a net cash position of $312.81 million or $7.08 per share.

Cash & Cash Equivalents	312.82M
Total Debt	14,000
Net Cash	312.81M
Net Cash Per Share	$7.08
Equity (Book Value)	307.22M
Book Value Per Share	7.24
Working Capital	306.95M

Cash Flow

Operating Cash Flow	-160.59M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.22%
Shareholder Yield	-22.22%
Earnings Yield	-15.04%
FCF Yield	n/a

Analyst Forecast

The average price target for AVBP is $40.20, which is 62.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.20
Price Target Difference	62.03%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1